好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Parkinson's Disease in patients with Essential Tremor: a prospective clinical and functional neuroimaging assessment
Movement Disorders
P1 - Poster Session 1 (9:00 AM-5:00 PM)
276
Relate the results of TRODAT-SPECT imaging in patients with ET with potential progress to ET-PD
Patients with essential tremor (ET) have 3.5 times greater risk of developing Parkinson's disease (PD) throughout their lives, also known as ET-PD. Single photon emission computed tomography with radiotracer imaging of dopamine transporters (TRODAT-SPECT) can help differentiate these two diseases.
Thirty-six patients with ET were evaluated by neurological examination, the Archimedes spiral, and the MDS-UPDRS III scale on two occasions, after a mean interval of three years. SPECT was performed in all patients after the first visit.
Overall, six patients (16.6%) progressed clinically to ET-PD. Patients with ET-PD were older and age of tremor onset was later. The ET-PD group scored higher on the MDS-UPDRS III scale, especially for the presence of bradykinesia. SPECT imaging was altered in 83.3% of the ET-PD patients compared to 33% of the ET patients (p=0.034). Changes on the SPECT with asymmetrical hypouptake suggested progress to ET-PD (p=0.025).

Advanced age at onset of tremor, presence of bradykinesia and asymmetrical alteration in SPECT may be related to progression to PD in patients with ET. Changes in neuroimaging suggest that SPECT-TRODAT can be used to predict progress to PD in selected patients.

Authors/Disclosures

PRESENTER
No disclosure on file
Carlos Henrique F. Camargo, MD, PhD, MSc, FAAN (Inovare Serviços de Saude Ltda.) Dr. Camargo has nothing to disclose.
Giorgio Fabiani, MD (Dr. Giorgio Fabiani) Dr. Fabiani has nothing to disclose.
No disclosure on file
Rui Kleber Martins-Filho No disclosure on file
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.